14-day Premium Trial Subscription Try For FreeTry Free
$2.04
+0.0700 (+3.55%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Apr 15, 2024 Buy 400 000 San Martin Javier Stock Option (Right to Buy)
Apr 15, 2024 Buy 0 San Martin Javier
Feb 15, 2024 Buy 650 000 Litton Mark James Stock Option (Right to Buy)
Feb 14, 2024 Buy 220 000 Worthington Mark Stock Option (Right to Buy)
Feb 14, 2024 Buy 220 000 Church Kevin Stock Option (Right to Buy)
Feb 14, 2024 Buy 280 000 Gengos Andrew Stock Option (Right to Buy)
Feb 14, 2024 Buy 300 000 Lenington Rachel Stock Option (Right to Buy)
Jan 05, 2024 Sell 1 208 Gengos Andrew Common Stock
Jan 05, 2024 Sell 2 412 Church Kevin Common Stock
Jan 05, 2024 Sell 4 820 Litton Mark James Common Stock
Jan 05, 2024 Sell 2 412 Worthington Mark Common Stock
Jan 05, 2024 Sell 2 412 Lenington Rachel Common Stock
Jan 04, 2024 Buy 5 000 Gengos Andrew Common Stock
Jan 04, 2024 Buy 10 000 Church Kevin Common Stock
Jan 04, 2024 Buy 10 000 Moebius Hans Common Stock
Jan 04, 2024 Buy 20 000 Litton Mark James Common Stock
Jan 04, 2024 Buy 10 000 Worthington Mark Common Stock
Jan 04, 2024 Buy 10 000 Lenington Rachel Common Stock
Dec 29, 2023 Buy 163 954 Perceptive Advisors Llc Common Stock
Dec 28, 2023 Buy 409 598 Perceptive Advisors Llc Common Stock
Dec 27, 2023 Buy 32 134 Perceptive Advisors Llc Common Stock
Nov 20, 2023 Buy 3 397 Church Kevin Common Stock
Jun 07, 2023 Buy 11 719 Gengos Andrew Common Stock
Jun 07, 2023 Buy 2 859 Gengos Andrew Common Stock
Jun 07, 2023 Buy 422 Gengos Andrew Common Stock
Jun 05, 2023 Buy 10 000 Gengos Andrew Common Stock
Jun 05, 2023 Buy 10 000 Gengos Andrew Common Stock
Jun 05, 2023 Buy 10 000 Gengos Andrew Common Stock
Jun 05, 2023 Buy 15 000 Gengos Andrew Common Stock
Jun 02, 2023 Buy 3 418 Gengos Andrew Common Stock
Jun 02, 2023 Buy 6 582 Gengos Andrew Common Stock
Jun 02, 2023 Buy 10 012 Gengos Andrew Common Stock
Jun 02, 2023 Buy 7 882 Moebius Hans Common Stock
Jun 02, 2023 Sell 7 882 Moebius Hans Stock Option (Right to Buy)
May 19, 2023 Buy 20 900 Romano Kelly A Stock Option (Right to Buy)
May 19, 2023 Buy 20 900 Johnson James A Stock Option (Right to Buy)
May 19, 2023 Buy 20 900 Kosacz Barbara Stock Option (Right to Buy)
May 19, 2023 Buy 20 900 Edelman Joseph Stock Option (Right to Buy)
May 19, 2023 Buy 20 900 Panzara Michael A. Stock Option (Right to Buy)
May 19, 2023 Buy 20 900 Fluke John M Jr Stock Option (Right to Buy)
May 19, 2023 Buy 20 900 Pickering Grant Stock Option (Right to Buy)
May 18, 2023 Buy 7 767 Worthington Mark Common Stock
May 18, 2023 Buy 809 Church Kevin Common Stock
May 18, 2023 Buy 7 764 Moebius Hans Common Stock
May 18, 2023 Buy 400 000 Gengos Andrew Stock Options (right to buy)
May 18, 2023 Buy 0 Gengos Andrew No securities are beneficially owned
Mar 30, 2023 Buy 15 000 Pickering Grant Common Stock
Mar 29, 2023 Buy 10 000 Pickering Grant Common Stock
Mar 29, 2023 Buy 5 000 Johnson James A Common Stock
Mar 24, 2023 Buy 6 410 Church Kevin Common Stock
Mar 24, 2023 Sell 6 410 Church Kevin Stock Option (Right to Buy)
Jan 27, 2023 Buy 425 000 Litton Mark James Stock Option (Right to Buy)
Jan 19, 2023 Buy 150 000 Worthington Mark Stock Option (Right to Buy)
Jan 19, 2023 Buy 200 000 Moebius Hans Stock Option (Right to Buy)
Jan 19, 2023 Buy 150 000 Mileson Glenna Stock Option (Right to Buy)
Jan 19, 2023 Buy 200 000 Lenington Rachel Stock Option (Right to Buy)
Jan 19, 2023 Buy 150 000 Church Kevin Stock Option (Right to Buy)
Jan 05, 2023 Sell 1 208 Gengos Andrew Common Stock
Jan 05, 2023 Sell 2 412 Church Kevin Common Stock
Jan 04, 2023 Buy 5 000 Gengos Andrew Common Stock
Jan 04, 2023 Buy 10 000 Church Kevin Common Stock
Dec 28, 2022 Buy 50 000 Mileson Glenna Common Stock
Dec 02, 2022 Buy 30 000 Romano Kelly A Common Stock
Nov 18, 2022 Buy 662 Litton Mark James Common Stock
Nov 18, 2022 Buy 657 Church Kevin Common Stock
Nov 18, 2022 Buy 763 Mileson Glenna Common Stock
Nov 15, 2022 Buy 5 000 Moebius Hans Common Stock
Oct 28, 2022 Buy 3 700 Church Kevin Common Stock
Oct 28, 2022 Sell 3 700 Church Kevin Stock Option (Right to Buy)
Oct 13, 2022 Buy 7 881 Moebius Hans Common Stock
Oct 13, 2022 Sell 7 881 Moebius Hans Stock Option (Right to Buy)
Jun 30, 2022 Buy 1 101 362 Perceptive Advisors Llc Common Stock
Jun 29, 2022 Buy 270 000 Perceptive Advisors Llc Common Stock
Jun 29, 2022 Buy 270 000 Edelman Joseph Common Stock
Jun 28, 2022 Buy 10 000 Moebius Hans Common Stock
Jun 22, 2022 Buy 10 000 Worthington Mark Common Stock
Jun 22, 2022 Sell 2 614 Worthington Mark Common Stock
Jun 22, 2022 Buy 10 000 Moebius Hans Common Stock
Jun 22, 2022 Sell 2 614 Mileson Glenna Common Stock
Jun 22, 2022 Buy 1 721 Mileson Glenna Common Stock
Jun 22, 2022 Buy 20 000 Litton Mark James Common Stock
Jun 22, 2022 Sell 7 960 Litton Mark James Common Stock
Jun 22, 2022 Buy 10 000 Lenington Rachel Common Stock
Jun 22, 2022 Sell 4 193 Lenington Rachel Common Stock
Jun 22, 2022 Buy 10 000 Church Kevin Common Stock
Jun 22, 2022 Sell 2 614 Church Kevin Common Stock
Jun 08, 2022 Buy 243 Church Kevin Common Stock
Jun 08, 2022 Sell 2 500 Church Kevin Stock Option (Right to Buy)
May 20, 2022 Buy 3 467 Pickering Grant Stock Option (Right to Buy)
May 20, 2022 Buy 3 467 Pickering Grant Stock Option (Right to Buy)
May 20, 2022 Buy 13 871 Romano Kelly A Stock Option (Right to Buy)
May 20, 2022 Buy 13 871 Romano Kelly A Stock Option (Right to Buy)
May 20, 2022 Buy 13 871 Kosacz Barbara Stock Option (Right to Buy)
May 20, 2022 Buy 13 871 Kosacz Barbara Stock Option (Right to Buy)
May 20, 2022 Buy 13 871 Edelman Joseph Stock Option (Right to Buy)
May 20, 2022 Buy 13 871 Edelman Joseph Stock Option (Right to Buy)
May 20, 2022 Buy 13 871 Fluke John M Jr Stock Option (Right to Buy)
May 20, 2022 Buy 13 871 Fluke John M Jr Stock Option (Right to Buy)
May 20, 2022 Buy 13 871 Johnson James A Stock Option (Right to Buy)
May 18, 2022 Buy 757 Litton Mark James Common Stock
JSON CSV
INSIDER POWER
96.287
Last 100 transactions
Buy: 6 665 546 | Sell: 65 252 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 96.287.

In total, the insiders bought 6 665 546 and sold 65 252 ATHA shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Athira Pharma, Inc.

Athira Pharma. Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkins... ATHA Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT